Nkt cell-activating agents containing .alpha.-glycosylceramides

Details Nkt cell-activating agents containing .alpha.-glycosylceramides Nkt cell-activating agents containing .alpha.-glycosylceramides

A - Human Necessities

61

K

A61K 31/7032 (2006.01) A61K 31/7028 (2006.01) A61P 3/10 (2006.01) A61P 37/06 (2006.01)

Patent

CA 2286482

NKT cell activators, remedies for autoimmune diseases (for example, systemic erythematodes, systemic scleroderma, ulcerative colitis, encephalomyelitis, multiple sclerosis and human type I diabetes) and abortifacients. These drugs contain as the active ingredient .alpha.- glycosylceramides of general formula (I) or salts or solvates of the same.

L'invention concerne des activateurs de cellules NKT, de médicaments destinés à des maladies auto-immunes (par exemple des maladies érythémateuses disséminées, des sclérodermies disséminées, des rectocolites hémorragiques, des encéphalomyélites, la sclérose en plaque et le diabète humain de type I) ainsi que des abortifs. Ces médicaments contiennent en tant que principe actif des alpha -glycosylcéramides correspondant à la formule générale (I), ou des sels ou solvates de ceux-ci.

Affiliated with

Also associated with

Rating

Nkt cell-activating agents containing .alpha.-glycosylceramides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nkt cell-activating agents containing .alpha.-glycosylceramides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nkt cell-activating agents containing .alpha.-glycosylceramides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1873359